Mapping out the Peripheral Nervous System for Neuromodulation Protocols to Prevent/Treat T2D

The session outlines how peripheral nervous system mapping informs non‑invasive neuromodulation protocols and AI facial analysis to detect and improve glucose regulation in type 2 diabetes.

Overview

UltraNeuro is a healthcare technology company developing non-invasive solutions for early detection and management of type 2 diabetes (T2D). Its platform includes:
• AI-driven facial analysis designed to identify early indicators of gestational and type 2 diabetes risk.
• A non-invasive neuromodulation device aimed at improving metabolic function and supporting healthy neural activity associated with glucose regulation.

Tech stack